0.000USD0.000盘后交易 12/16, 20:00 (美东)
操作建议
Kenvue Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在个人与家用产品服务行业排名21/36位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价19.55。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Kenvue Inc简介
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
公司代码KVUE
公司Kenvue Inc
CEOPerry (Kirk L)
网址https://www.kenvue.com
常见问题
Kenvue Inc(KVUE)的当前股价是多少?
Kenvue Inc(KVUE)的当前股价是 17.210。
Kenvue Inc股票的52周最高点是25.170。
Kenvue Inc股票的52周最低点是14.020。
现在Kenvue Inc(KVUE)的股票是买入、持有还是卖出?
根据分析师评级,Kenvue Inc(KVUE)的总体评级为持有,目标价格为19.547。
Kenvue Inc(KVUE)股票的每股收益(EPS TTM)是多少
Kenvue Inc(KVUE)股票的每股收益(EPS TTM)是0.748。